Oculis' main value driver appears to be OCS-01, which targets a respectable $4B DME TAM with its non-invasive eye drops. See ...

The benefits of wearing multifocal contact lenses to slow myopia continue even after the lenses are no longer used.

Medication, laser, and surgery are all methods of treating glaucoma according to Jonathan Eisengart, MD. Jonathan Eisengart, MD, an ophthalmologist at Cleveland Clinic, explained how different ...

A new report shows the benefit of wearing contact lenses for slowing myopia has a lasting effect -- good news since 50% of the world (5 billion people) will likely be nearsighted by 2050.

A novel presbyopia drop improves near vision using pupillary constriction to create a pinhole effect, while allowing good distance vision.

Perfluorohexyloctane and lotilaner ophthalmic solution, 2 ocular surface disease drugs, have changed the DED and DB treatment paradigms.